Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

384 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neuropsychiatric symptoms in Systemic Lupus Erythematosus: mixed methods analysis of patient-derived attributional evidence in the international INSPIRE project.
Sloan M, Pollak TA, Massou E, Leschziner G, Andreoli L, Harwood R, Bosley M, Pitkanen M, Diment W, Bortoluzzi A, Zandi MS, Ubhi M, Gordon C, Jayne D, Naughton F, Barrere C, Wincup C, Brimicombe J, Bourgeois JA, D'Cruz D. Sloan M, et al. Among authors: d cruz d. Rheumatology (Oxford). 2024 Mar 22:keae194. doi: 10.1093/rheumatology/keae194. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38518094
Early infection risk in patients with systemic lupus erythematosus treated with rituximab or belimumab from the British Isles Lupus Assessment Group Biologics Register (BILAG-BR): a prospective longitudinal study.
Rodziewicz M, Dyball S, Lunt M, McDonald S, Sutton E, Parker B, Bruce IN; British Isles Lupus Assessment Group Biologics Register (BILAG-BR) consortium. Rodziewicz M, et al. Lancet Rheumatol. 2023 May;5(5):e284-e292. doi: 10.1016/S2665-9913(23)00091-7. Lancet Rheumatol. 2023. PMID: 38251591 Free article.
Lupus Nephritis Outcomes after Stopping Immunosuppression.
Alenzi F, Ateka-Barrutia O, Ken Cheah C, Khamashta M, Sangle SR, D'Cruz DP. Alenzi F, et al. Among authors: d cruz dp. J Clin Med. 2024 Apr 11;13(8):2211. doi: 10.3390/jcm13082211. J Clin Med. 2024. PMID: 38673484 Free PMC article.
Lupus enteritis: a narrative review.
Muñoz-Urbano M, Sangle S, D'Cruz DP. Muñoz-Urbano M, et al. Among authors: d cruz dp. Rheumatology (Oxford). 2024 Jan 12:kead689. doi: 10.1093/rheumatology/kead689. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38216993
Long-Term Effectiveness of Benralizumab in Eosinophilic Granulomatosis With Polyangiitis.
Nanzer AM, Maynard-Paquette AC, Alam V, Green L, Thomson L, Lam J, Fernandes M, Roxas C, d'Ancona G, Hearn A, Gates J, Agarwal S, Kent BD, Fernando M, D'Cruz DP, Hopkins C, Ismail TF, Dhariwal J, Jackson DJ. Nanzer AM, et al. Among authors: d cruz dp. J Allergy Clin Immunol Pract. 2024 Mar;12(3):724-732. doi: 10.1016/j.jaip.2024.01.006. Epub 2024 Jan 9. J Allergy Clin Immunol Pract. 2024. PMID: 38211889
Attribution of neuropsychiatric symptoms and prioritisation of evidence in the diagnosis of neuropsychiatric lupus: mixed methods analysis of patient and clinician perspectives from the international INSPIRE study.
Sloan M, Andreoli L, Zandi MS, Harwood R, Pitkanen M, Sloan S, Barrere C, Massou E, Wincup C, Bosley M, Naughton F, Ubhi M, Jayne D, Leschziner G, Brimicombe J, Diment W, Middleton K, Gordon C, D'Cruz D, Pollak TA. Sloan M, et al. Among authors: d cruz d. Rheumatology (Oxford). 2023 Dec 18:kead685. doi: 10.1093/rheumatology/kead685. Online ahead of print. Rheumatology (Oxford). 2023. PMID: 38105443
384 results